Detalles de la búsqueda
1.
Analysis of serum glycome by lectin microarrays for prostate cancer patients - a search for aberrant glycoforms.
Glycoconj J;
37(6): 703-711, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33119808
2.
Responder and health-related quality of life analyses in men with lower urinary tract symptoms treated with a fixed-dose combination of solifenacin and tamsulosin oral-controlled absorption system: results from the NEPTUNE study.
BJU Int;
117(1): 165-72, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25907003
3.
Glycoprofiling of proteins as prostate cancer biomarkers: A multinational population study.
PLoS One;
19(3): e0300430, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38498504
4.
Synthesis and characterization of Au nanoshells with a magnetic core and betaine derivatives.
MethodsX;
6: 1999-2012, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31667097
5.
Advanced impedimetric biosensor configuration and assay protocol for glycoprofiling of a prostate oncomarker using Au nanoshells with a magnetic core.
Biosens Bioelectron;
131: 24-29, 2019 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30798249
6.
Aberrant sialylation of a prostate-specific antigen: Electrochemical label-free glycoprofiling in prostate cancer serum samples.
Anal Chim Acta;
934: 72-9, 2016 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-27506346
7.
Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension.
Eur Urol;
67(2): 262-70, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25070148
8.
Combination therapy with solifenacin and tamsulosin oral controlled absorption system in a single tablet for lower urinary tract symptoms in men: efficacy and safety results from the randomised controlled NEPTUNE trial.
Eur Urol;
64(6): 1003-12, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23932438
Resultados
1 -
8
de 8
1
Próxima >
>>